Acoustic Startle Reduction In Cocaine Dependence

NCT00430690 | Completed

• 2 other identifiers: IRB00002489R01DA018294-01A2
• Study Type: observational
• Target: 144
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic cocaine administration leads to changes in brain function that persist long after the acute withdrawal phase. The acoustic startle response (ASR) is a well characterized reflexive response to a sudden acoustic stimulus. The ASR is mediated by a simple 3-synapse subcortical circuit; it is modulated in part by brain areas and neurotransmitters associated with cocaine administration. Our initial study and subsequent replication reveals a profound diminution of the ASR in cocaine-dependent subjects after a brief period of abstinence. Our preliminary findings indicate that first degree relatives of cocaine-dependent subjects also have reduced startle compared to healthy controls. The findings of low ASR in rats and humans during cocaine washout and low ASR in family members suggests there may be both a trait and state component of the startle reductions we have reported. The central objectives of this proposal are to dissect this finding with regard to its development and persistence in early and later phases of cocaine abstinence in humans; to ascertain whether startle reduction and its potential normalization during later abstinence is a predictor of clinical course in human subjects with cocaine dependence; and to examine whether startle reduction is, at least in part, a vulnerability trait for the development of cocaine dependence. This latter Aim will be carried out in humans by testing siblings of cocaine-dependent subjects. Cocaine dependence is an enormous public health problem. The significance of this work lies in the potential for the ASR reduction to serve as a reliable, easily repeatable biological measure of cocaine-induced brain changes that may enhance outcome prediction so that tailored treatments may be directed at those patients most vulnerable to relapse, given the restriction of resources for available for substance abuse treatment.

Conditions

Cocaine-Related Disorders

Outcome Measures

Primary Outcomes (1)

• Acoustic startle magnitude

  Magnitude of acoustic startle response as measured by electromyography of eyeblink.

  at baseline

Study Arms (3)

1

Cocaine dependent subjects

Procedure: acoustic startle testing

2

Healthy controls

Procedure: acoustic startle testing

3

Siblings of cocaine dependent subjects

Procedure: acoustic startle testing

Interventions

acoustic startle testing PROCEDURE

acoustic startle testing: listening to sounds through headphones while the eyeblink component of the acoustic startle reflex is recorded with small surface electrodes

1; 2; 3

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Subjects with cocaine dependence who are entering substance abuse treatment; siblings of these subjects; and healthy controls

You may qualify if:

• Cocaine dependent subjects:
• males or females,
• age 18-80,
• with a DSM-IV diagnosis of cocaine dependence,
• a usage history characterized by a minimum of 1 year of at least $50 per day or weekly binges of at least $200 of cocaine use.

You may not qualify if:

• current clinically significant medical illness (including HIV, because of possible confound of neurological involvement),
• current or past neurological illness, and no history of head trauma with loss of consciousness ≥ 5 minutes because of the possible confound of neurological damage to startle-modulating brain areas,
• other Axis I psychiatric disorder currently or in the previous three months with the exception of substance induced disorders as determined by SCID,
• history of schizophrenia, schizoaffective disorder, posttraumatic stress disorder, or bipolar disorder,
• known hearing impairments (intact hearing will be insured by brief audiology screening),
• dependence on other drugs or alcohol within the previous 6 months, as confirmed by ASI.
• Healthy controls:
• males or females,
• age 18-80.
• history of any Axis I psychiatric illness or history of treatment as determined by SCID Axis I,
• substance dependence or abuse history by ASI and SCID,
• no current clinically significant medical illness (including HIV),
• current or past neurological illness, or history of head trauma with loss of consciousness ≥ 5 minutes because of the possible confound of neurological damage to startle-modulating brain areas,
• known hearing impairments (intact hearing will be insured by brief audiology screening),
• Axis I disorder, including substance dependence, in first degree family member.

Sponsors & Collaborators

• Emory University: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

Atlanta Veterans Adminstration Medical Center

Decatur, Georgia, 30033, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood and extracted DNA

MeSH Terms

Conditions

Cocaine-Related Disorders

Condition Hierarchy (Ancestors)

Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders

Study Officials

• Erica Duncan, MD

  Emory University / Atlanta VA

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: February 1, 2007
• First Posted: February 2, 2007
• Study Start: September 1, 2006
• Primary Completion: July 19, 2011
• Study Completion: July 19, 2011
• Last Updated: August 7, 2019

Record last verified: 2019-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)